Correspondence  by unknown
deaths due to pump failure and arrhythmias are lessened by successful
reperfusion. It is also conceivable that late ruptures are prevented by
myocardial salvage, once again creating the impression that reperfu-
sion increases the risk of rupture when early mortality is the end point.
We found that despite an “acceleration” of rupture events, mortality
was lower in thrombolytic-treated patients, mitigating against an “early
hazard.”
In the pre-reperfusion era, intravenous beta-blocker administration
(5) and previous MI were thought to protect against rupture. We were
somewhat surprised to find the opposite and cannot offer an explana-
tion at this time. However, as scientific investigators we acknowledge
that reperfusion, thrombolytic therapy and antithrombotic strategies
may create a unique pathologic environment quite different from that
in the pre-reperfusion era (8).
In the GISSI study (9), patients .70 years old had an autopsy-
determined rupture rate of 86%. Our findings are unlikely to decrease
thrombolytic therapy use. Indeed, clinicians are aware that elderly
patients experience an alarmingly high in-hospital mortality rate and,
as a result, stand to benefit greatly from aggressive treatment. Potential
risks and benefits must always be weighed carefully.
The NRMI is the largest observational data base (of MI) in the
United States and currently includes information on .500,000 pa-
tients. Like other registries it is not a substitute for basic investigation
nor can it solve mechanistic questions. The NRMI does serve a vital
role in tracking health care trends and outcomes as well as in
identifying areas in medicine that require more in-depth study.
RICHARD C. BECKER, MD
Cardiovascular Thrombosis Research Center
University of Massachusetts Medical Center
55 Lake Avenue North
Worcester, Massachusetts 01655-0214
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Qualitative or Quantitative Assessment of
Spontaneous Echo Contrast?
We note with interest the study by Klein et al. (1) in a recent issue of
the Journal in which a new method of assessing the intensity of left
atrial spontaneous echo contrast (SEC) using integrated backscatter
was compared with a qualitative grading method. We agree with the
authors that the severity of SEC is likely to be an important variable in
stratification of thromboembolic risk, particularly in patients with
nonvalvular atrial fibrillation. Several methods of classifying the sever-
ity of SEC on the basis of factors such as its intensity, distribution
within the left atrium and the gain settings at which it is detected have
been reported previously (2–4). We are concerned by the premise of
Klein et al. that qualitative grading is neither objective nor reproduc-
ible, with the implication that quantitative grading of SEC is required.
Klein et al. claim that interobserver variability is a major limitation
of existing qualitative grading methods. The main evidence cited in
support of this argument is a study by Kronik et al. (5), in which SEC
grading was performed in 88 patients by two independent observers
from two separate laboratories. Kronik et al. found that there was
“good” agreement between the observers (kappa value 0.65) in the
grades allocated. In the study by Klein et al., SEC grades were
determined by consensus of two observers from the same laboratory.
The number of cases in which a discrepancy occurred was not included
in their report. We devised a method of classifying SEC into five grades
that we have used for .7 years in our laboratory. The variability of
SEC grading by two experienced observers using this method (6%) (4)
is comparable to the interobserver variability reported by Klein et al.
for integrated backscatter measurements (4%). In their study, Klein et
al. found a strong, positive correlation between SEC grade and the
integrated backscatter intensities (r 5 0.89, p , 0.001). In a recent
report (6), we demonstrated that qualitative grades correlated highly
with quantitative assessment of SEC using videodensitometric analysis
(r 5 0.85, p , 0.001).
Klein et al. propose a multicenter trial to establish the prognostic
significance of left atrial integrated backscatter measurements. Several
factors need to be considered in designing such a trial: 1) The results
are likely to be confounded by the effects of anticoagulant therapy.
Given the relation between left atrial SEC and left atrial thrombus
(2–4), it would be unethical to withhold or randomize anticoagulant
treatment, particularly in patients with higher grades of SEC. A high
prevalence of anticoagulation in patients with severe SEC would be
expected to mitigate against the demonstration of a positive
relation between SEC grade and thromboembolic events. 2) Al-
though Klein et al. estimate a sample size of 350 patients, we suspect
that a considerably larger number of patients may be required to
achieve statistically significant differences between groups in an anti-
coagulated population. 3) The cost of recruiting patients and providing
integrated backscatter software to a large number of centers needs to
be evaluated.
Integrated backscatter as a continuous variable is unlikely to be of
great benefit to practical clinical decision making. A major objective of
a prospective trial would be to establish a “cutoff” value above which
prophylactic anticoagulation could be recommended. This binary
outcome is unlikely to be more informative than a qualitative estimate,
such as the presence or absence of moderate/severe SEC. Although
quantitative assessment of SEC by integrated backscatter provides an
interesting new research tool, we propose that qualitative grading may
be adequate for the majority of clinical studies.
DIANE FATKIN, MBBS, BSC(MED), FRACP
MICHAEL P. FENELEY, MD, FRACP, FACC
Cardiology Department and Victor Chang Cardiac Research Institute
St. Vincent’s Hospital
Victoria Street
Darlinghurst 2010, Australia
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Reply
We thank Fatkin and Feneley for their interest in our report (1). The
main point of the study was that integrated backscatter provides an
objective measure of spontaneous echo contrast (SEC) that correlates
well with qualitative grading and with clinical and echocardiographic
variables of thromboembolism. They express concern with our premise
that the traditional qualitative grading of SEC (2,3) is neither objective
nor reproducible relative to the proposed method of quantification of
SEC.
Fatkin and Feneley point to the “good” agreement (kappa value
0.65) in the qualitative grading of SEC reported by Kronik et al. (4). In
that study, the kappa value reflects the off-line interobserver variability
(i.e., variability in the interpretation by two observers of videotape
images generated by a single observer). In fact, there was disagreement
in the grading in 17% of cases, probably an unacceptably high
proportion. True interobserver variability critically includes not only
differences in image interpretation, but also variability resulting from
different image acquisition, including the effect of imaging planes, gain
and depth settings. It may also include the reported intermachine
variability in the detection of SEC among different commercial echo-
cardiographic machines (5).
A more recent study (6) further highlights the variability in
interpretation of SEC. The Stroke Prevention in Atrial Fibrillation
(SPAF) Investigators (6), reported kappa values ranging from 0.47 to
0.67 for the detection and grading of SEC in the left atrium or left
atrial appendage by 20 highly experienced echocardiographers, using
preacquired videotape images and a manual of operations.
The comparison between SEC grade and integrated backscatter
intensities in our report reflect true interobserver reliability because it
involved data that were derived from separate acquisitions and sepa-
rate interpretations. The integrated backscatter image sequence was
obtained after the transesophageal echocardiographic study using its
own calibration system and was analyzed using the acoustic densitom-
etry system in blinded manner by a technician who had no knowledge
of the qualitative grade (1).
Fatkin and Feneley have developed a SEC grading system using
five grades (7) and have shown an interobserver variability of 6% and
a good correlation with off-line videodensitometry. That study involved
a videodensitometric scoring of the same image from which the
qualitative grade was derived. The videodensitometric scoring is
affected by a nonlinearity of the ultrasound signal that includes the
effects of log compression and postprocessing that develops the
two-dimensional image in commercial echocardiographic machines
(1). Furthermore, their proposed grading system may work in very
experienced hands within the same laboratory, but we believe that
training and experience are important in obtaining good agreement in
qualitative grading systems. Conversely, we believe that operator
experience has relatively less effect on variability in the digital acqui-
sition and analysis of SEC by integrated backscatter, provided that the
operator properly calibrates the backscatter intensity of the image as
outlined in our report (1). One of the remarkable features of the
integrated backscatter system is that the software digitally documents,
on an optical disk, all the crucial system settings, such as gain and
compression. The clear benefit is that the clinician can set up the
system identically, thereby enhancing reproducibility and accuracy in
serial studies on the same patient.
Fatkin and Feneley point out some potential pitfalls in using SEC
to predict thromboembolic risk in patients with atrial fibrillation. In
their study (8), they found that SEC did not predict embolic events
reliably, especially in an anticoagulated population. This finding is in
contrast to the study by Leung et al. (9) who showed that patients with
SEC have a higher risk of developing stroke or embolic events
(12%/year vs. 3%/year) than patients without SEC. Of note, 34% of
patients with SEC were receiving anticoagulant therapy in that study.
Those embolic event rates were used as assumptions in the sample size
estimate of 350 patients for our ongoing prospective multicenter study
using integrated backscatter. The cost of recruiting patients and the
availability of the software may not be so limiting because the
integrated backscatter software system is now commercially available
from the manufacturer.
We agree with Fatkin and Feneley on the importance of establish-
ing a clinically important cutoff for the severity of SEC, above which
prophylactic anticoagulation should be recommended. A major objec-
tive of a multicenter trial would be to establish a clinical relevant
“cutoff” value from the continuous integrated backscatter data. It is
not known whether these clinically relevant cutoff values may be the
same as the arbitrary divisions that now exist between qualitative
grades.
We concur that the currently used qualitative grading of SEC may
be adequate for the majority of clinical studies. However, we maintain
that assigning a qualitative grade to a continuous variable such as SEC
inherently involves some element of subjectivity, and the technical
aspects of image acquisition can introduce additional variability. For
these reasons, we believe that a method to quantify SEC is a necessary
pursuit to objectively validate the significance and potential clinical
value of this phenomenon.
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